Organización Mundial de la Salud (OMS). Reporte de WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. Ginebra: OMS; 2020 [citado 8 marzo 2021]. Disponible en: https://who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Khan M, Khan H, Khan S, Nawaz M. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a singlecentre study. J Med Microbiol. 2020;69(8):1114-23. https://doi.org/10.1099/jmm.0.001231
Organización Panamericana de la Salud (OPS). Informes de situación de la COVID-19 [Internet]. [citado 2 marzo 2021]. Disponible en: https://www.paho.org/es/informes-situacion-covid-19
Miró Ò, Alquézar-Arbé A, Llorens P, Martín-Sánchez F, Jiménez S, Martín A, et al. Comparación de las características demográficas y comorbilidad de los pacientes con COVID-19 fallecidos en hospitales españoles, en función de si ingresaron o no en Cuidados Intensivos. Medicina Intensiva [Internet]. 2021 [citado 13 marzo 2021];45(1):14-26. https://doi.org/10.1016/j.medin.2020.09.002
COVID-19 Map. Johns Hopkins Coronavirus Resource Center [Internet]. Johns Hopkins Coronavirus Resource Center. 2021 [citado 9 marzo 2021]. Disponible en: https://coronavirus.jhu.edu/map.html
COVID-19: Situation report [Internet]. Interactive.afp.com. 2021 [citado 9 marzo 2021]. Disponible en: https://interactive.afp.com/graphics/COVID-19-Situation-report_605
Boletín #384 Enfermedad por coronavirus 2021 [internet]. Santo Domingo (RD): Gobierno de la República Dominicana, Salud Pública. Dirección General de Epidemiología. [citado 13 marzo 2021]. Disponible en: https://www.msp.gob.do/web/?page_id=6948
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 [citado 13 marzo 2021];382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032
Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052. https://doi.org/10.1001/jama.2020.6775
Organización Mundial de la Salud (OMS). Weekly epidemiological update - 2 March 2021 [Internet]; [citado 8 marzo 2021]. Disponible en: https://www.who.int/publications/m/item/weekly-epidemiological-update---2-march-2021
Organización Mundial de la Salud (OMS). COVID-19 Clinical management: living guidance [Internet]. Who.int. 2021 [citado 13 marzo 2021]. Disponible en: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1
Sabatier C, Peredo R, Villagrá A, Bacelar N, Mariscal D, Ferrer R, et al. Neumonía comunitaria grave. Estudio descriptivo de 7 años y utilidad de los criterios de la Infectious Diseases Society of America y la American Thoracic Society 2007 en la identificación de los pacientes que requieren ingreso en una unidad de cuidados intensivos. Medicina Intensiva. 2010;34(4):237-45. https://doi.org/10.1016/j.medin.2009.11.008
Zheng X, Chen J, Deng L, Fang Z, Chen G, Ye D. Risk factors for the COVID‐19 severity and its correlation with viral shedding: A retrospective cohort study. J Med Virol [Internet]. 2021 Feb;93(2):952-61. https://doi.org/10.1002/jmv.26367
Petrilli C, Jones S, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020; m1966. https://doi.org/10.1136/bmj.m1966
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M. Age and Multimorbidity Predict Death Among COVID-19 Patients. Hypertension [Internet]. 2020 Aug;76(2):366-72. https://doi.org/10.1161/HYPERTENSIONAHA.120.15324
Fang X, Li S, Yu H, Wang, Zhang Y, Chen Z, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) [Internet]. 2020 Jul 15;12(13):12493-503. https://doi.org/10.18632/aging.103579
Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21:74. https://doi.org/10.1186/s12931-020-01338-8
Webb K, Peckham H, Radziszewska A, Menon M, Oliveri P, Simpson F, et al. Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration. Front Immunol. 2018;9:3167. https://doi.org/10.3389/fimmu.2018.03167
Pietrobon AJ, Teixeira FM and Sato NM. Immunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People. Front Immunol. 2020;11:579220. https://doi.org/10.3389/fimmu.2020.579220
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62.
Gold M, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and metaanalysis. Postgraduate Medicine. 2020;132(8):749-55. https://doi.org/10.1080/00325481.2020.1786964
Pranata R, Lim M, Huang I, Raharjo S, Lukito A. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst. 2020;21(2):147032032092689. https://doi.org/10.1177/1470320320926899
Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821-9. https://doi.org/10.1093/eurheartj/ehaa388
Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. https:// doi.org/10.1093/cvr/cvaa106
Varikasuvu S, Dutt N, Thangappazham B, Varshney S. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality. Prim Care Diab. 2021;15(1):24-7. https://doi.org/10.1016/j.pcd.2020.08.015
Drucker D. Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications. Endoc Rev. 2020;41(3):457-70. https://doi.org/10.1210/endrev/bnaa011
Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020;96(1137):403-7. http://dx.doi.org/10.1136/postgradmedj-2020-137935
Zhang X, Yu J, Pan L, Jiang H. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A T systematic review and metaanalysis. Pharmacl Res. 2020;158:104927. https://doi.org/10.1016/j.phrs.2020.104927
Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012;345:1-20. https://doi.org/10.1136/bmj.e4260
Saeed O, Castagna F, Agalliu I, Xue X, Patel S, Rochlani Y, et al. Statin Use and In‐Hospital Mortality in Patients with Diabetes Mellitus and COVID‐19. JAMA. 2020;9(24). https://doi.org/10.1161/JAHA.120.018475
Reiner Ž, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T, et al. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci. 2020;16(3):490-6. https://doi.org/10.5114/aoms.2020.94655
Hariyanto T, Kurniawan A. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. Diabetes Metabo Syndr. 2020;14(6):1613-5. https://doi.org/10.1016/j.dsx.2020.08.023
Yuan S, Chen P, Li H, Chen C, Wang F, Wang DW. Mortality and pre‐hospitalization use of lowdose aspirin in COVID‐19 patients with coronary artery disease. J Cellul Molec Med [Internet]. 2021;25(2):1263-73. https://doi.org/10.1111/jcmm.16198
Wang J, Jiang M, Chen X, Montaner L. Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biolog. 2020;108(1):17-41. https://doi.org/10.1002/JLB.3COVR0520-272R
Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. https://doi.org/10.1016/j.ebiom.2020.102763
Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33. Published online 2020 Mar 27. doi:10.1038/s4139 2-020-0148-4
Henry B, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. American J Emerg Med. 2020;38(9):1722-6. https://doi.org/10.1016/j.ajem.2020.05.073
Poggiali E, Zaino D, Immovilli P, Rovero L, Losi G, Dacrema A, et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clinica Chimica Acta. 2020;509:135-8. https://doi.org/10.1016/j.cca.2020.06.012
Elshazli R, Toraih E, Elgaml A, El-Mowafy M, El-Mesery M, Amin M, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLOS ONE. 2020;15(8):e0238160. https://doi.org/10.1371/journal.pone.0238160
Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Bordell A, et al. Características, evolución clínica y factores asociados a la mortalidad en UCI de los pacientes críticos infectados por SARS-CoV-2 en España: estudio prospectivo, de cohorte y multicéntrico. Rev Españ Anest Reanima. 2020;67(8):425-37. https://doi.org/10.1016/j.redar.2020.07.003
X.H. Yang, R.H. Sun, D.C. Chen. Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored. 2020;100(16):1205-8. https://doi.org/10.3760/cma.j.cn112137-20200229-00520
Chen F, Sun W, Sun S, Li Z, Wang Z, Yu L. Clinical characteristics and risk factors for mortality among inpatients with COVID‐19 in Wuhan, China. Clin Transl Med. 2020;10(2). https://doi.org/10.1002/ctm2.40
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb And Haem. 2020;18(7):1738-42. https://doi.org/10.1111/jth.14850
Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. Biomed Res Int. 2020;2020:6159720. Published online 2020 Jun 16. https://doi.org/10.1155/2020/6159720
